Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Wednesday, December 11, 2013 | Enzo Biochem and Flagship Biosciences Partner To Provide Tissue-Based Companion Diagnostics Offering Complete Solution For In Situ Hybridization Development To Pharmaceutical Companies |
Tuesday, December 10, 2013 | ENZO Biochem Reports First Fiscal Quarter Results Further Financial Progress Achieved On Sequential Basis |
Monday, December 09, 2013 | ENZO Biochem Schedules Teleconference To Discuss First Quarter Results Wednesday, December 11, 2013 At 8:30 AM E.T. |
Friday, November 15, 2013 | Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus Discovery Expected to Provide Reliable Marker for Diagnosis and Potential Treatment Enzo Developing Early Diagnostic |
Tuesday, October 29, 2013 | ENZO Biochem and Sequenom Partner To Market Key Sequenom Laboratories Prenatal Testing Service Partnership Underscores Strong Integrated Life Science-Clinical Lab Capabilities |
Thursday, October 17, 2013 | ENZO Biochem’s Clinical Lab And Biotech Leader Diasorincollaborate To Provide Advanced Clinical Technologies Positions Enzo Labs as “Center of Excellence” for Developing DiaSorin Assays |
Wednesday, October 16, 2013 | ENZO Biochem Reports Fourth Quarter And Fiscal Year Results Records Sequential Gains In Revenues, Margins, Operating Income, Company Prepares For Trial Next Month Seeking To Enforce Significant Contracts And Key Patents |
Tuesday, August 06, 2013 | Court Upholds $48.6 Million Jury Award to ENZO Biochem |
Tuesday, June 11, 2013 | Enzo Biochem, Inc. Enters Into $8.0 Million Senior Secured Revolving Credit Facility with Healthcare Finance Group, LLC |
Monday, June 10, 2013 | ENZO Biochem Reports Third Quarter Results Revenue and Gross Margin Improve Sequentially; Newly Approved Assays To Drive Revenue Growth at Clinical Labs, Higher Margin Products Improve Life Sciences Results |
Thursday, June 06, 2013 | ENZO Biochem Schedules Teleconference To Discuss Third Quarter Results On June 11, 2013 At 8:30 AM E.T. |
Tuesday, May 07, 2013 | ENZO And NIH File Patent Application For Therapies, Diagnosis, And Prognosis For Autoimmune Diseases |
Tuesday, March 12, 2013 | ENZO Biochem Reports Fiscal Second Quarter Results |